Bio-Rad

Bio-Rad Laboratories announced the launch of the 29th StarBright Dye, StarBright Red 670, and an expansion of its current range. With 29 additional targets the range also includes dog, cow, and pig targets.

This article discusses what good dPCR data looks like, how substandard equipment can detract from data quality and what oncology researchers can do to get high-quality dPCR data that will provide accurate and efficient insight into tumor load.

We spoke with Bio-Rad’s Justin Barker to discover some of the challenges associated with gene expression analysis in oncology and learn about technology developments in this field.

This article discusses the methodology of using common archived biospecimens for RNA sequencing in oncology applications, such as tumor profiling, introducing challenges and innovative solutions.

Test reintroduced to the market following regulatory and performance validation for UKCA marking.

For over 150 years, wastewater has provided a rich source of data for tracking infectious diseases and informing public health decisions. Since the COVID-19 pandemic, the scope for wastewater-based epidemiology (WBE) has increased significantly and requires increasingly rapid, versatile and accurate detection methods to monitor the spread of disease.

New applications for RNA therapeutics are continuously emerging. In this burgeoning space, nucleic acid quantification can help this dynamic therapeutic modality reach its full potential.

Immunotherapy aims to leverage the power of the immune system in the fight against cancer. It offers a more effective and less destructive approach than many traditional treatments.

Bio-Rad Laboratories, Inc. has announced the launch of its PTC Tempo 96 and PTC Tempo Deepwell Thermal Cyclers, designed to optimize PCR applications such as sequencing, cloning and genotyping.

In this informative video, you will discover the latest technologies and workflows used in the field of cell and gene therapy.